Zenas BioPharma to Host Virtual R&D Event

$ZBIOPress releaseOct 6, 2026, 7:05 AM ETRead the release

Zenas BioPharma will host a virtual R&D event on Tuesday, October 27, 2026, from 8:00 to 9:30 a.m. ET. Presentations will cover the pipeline including obexelimab, the company's bifunctional CD19/FcγRIIb antibody in systemic lupus erythematosus, and ZB021, an oral IL-17AA/AF inhibitor, with Dr. Joseph Merola providing clinical insights.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.